Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on October 7, 2026

Oct. 7, 2026

Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets

Indeterminate GlobeNewswire

Oct. 7, 2026

Crane NXT Appoints Jeong H. Kim to Board of Directors

Indeterminate GlobeNewswire

Oct. 7, 2026

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

Indeterminate GlobeNewswire

Oct. 7, 2026

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Indeterminate GlobeNewswire

Oct. 7, 2026

CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia

Indeterminate GlobeNewswire

Oct. 7, 2026

Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator

Indeterminate GlobeNewswire

Oct. 7, 2026

Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Indeterminate GlobeNewswire

Oct. 7, 2026

Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases

Indeterminate GlobeNewswire

Oct. 7, 2026

Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call

Indeterminate GlobeNewswire

Oct. 7, 2026

Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference

Indeterminate GlobeNewswire

Oct. 7, 2026

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

Premier American Uranium Reports 10 ft of 0.064% eU₃O₈ in Ongoing Drilling at Kaycee, Wyoming

Indeterminate GlobeNewswire

Oct. 7, 2026

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Indeterminate GlobeNewswire

Oct. 7, 2026

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

Indeterminate GlobeNewswire

Oct. 7, 2026

Redevances OR annonce ses livraisons préliminaires d’OEO pour le troisième trimestre de 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium

Indeterminate GlobeNewswire

Oct. 7, 2026

Alpha Compute’s GAMEE Reports Q3 Record 94% YoY Growth, Reaches Monthly Profitability with over 118 million game-plays, Expands Into AI-Powered Consumer Applications

Indeterminate GlobeNewswire